Seeking Alpha

  BioCryst Pharmaceuticals, Inc. - NASDAQ

11/29/2014, 12:32 AM ET
  • B___________ | Send Message 12 Jan 2013

    $BCRX about to POP above $2 on speculation.
      BCRX vs. ETF Alternatives
      Company Description
      Biocryst Pharmaceuticals Inc. is engaged in the design, optimization and development of novel drugs that block key enzymes involved in the pathogenesis of diseases. Its drug candidates include Peramivir, BCX4161, Forodesine and Ulodesine, among others.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States